From the Guidelines
NeoAging's Risk Checker Panel is a comprehensive health screening tool that assesses various biomarkers associated with aging and disease risk, providing a global risk assessment similar to the Framingham Risk Score, which is recommended by the American Heart Association for adults starting at age 20 1. The panel typically includes blood tests that measure key indicators like inflammatory markers, hormonal levels, metabolic function, cardiovascular health markers, and nutrient status.
- The panel helps identify potential health issues before they become serious problems, allowing for early intervention and personalized treatment plans.
- Results from this panel can guide healthcare providers in recommending specific lifestyle modifications, supplements, or medications tailored to address individual health concerns. The scientific rationale behind this approach is that many age-related diseases develop gradually with detectable biochemical changes occurring years before symptoms appear, and measuring frailty, as discussed in a 2021 study, can provide insights into clinical medicine and population health 1.
- By monitoring these biomarkers regularly, patients and healthcare providers can track improvements over time and adjust interventions accordingly.
- The panel is particularly valuable for those interested in preventive healthcare and longevity medicine, as it provides objective data to guide evidence-based decisions about health optimization strategies. According to a 2021 study published in Nature Aging, frailty is a multiply determined, age-related state of increased risk for adverse health outcomes, and measuring frailty can help explain the distinction between carrying damage and expressing its usual clinical manifestations 1.
- The study suggests that frailty can be modified or even prevented with appropriate interventions, making it a target of treatment.
- A global or multiple-risk factor assessment, such as the one provided by NeoAging's Risk Checker Panel, is essential for early recognition of risk factors and providing individualized care with the greatest benefit and lowest risk.
From the Research
Definition and Purpose
There is no direct information available about the Neo-Aging's Risk Checker Panel in the provided studies 2, 3, 4, 5, 6.
Related Concepts
However, the studies discuss various aspects of aging and its relationship to age-related diseases, including:
- The biological mechanisms of aging, such as genomic instability, telomere shortening, and cellular senescence 2, 5
- The role of aging as a risk factor for diseases, including cardiovascular disease, cancer, and neurodegenerative diseases 3, 5, 6
- The concept of inflammaging, which refers to the chronic, low-grade inflammation that develops during aging and contributes to the pathogenesis of age-related diseases 4
Key Findings
Some key findings from the studies include:
- Aging is a driving factor for various age-related diseases, and research has focused on elucidating the biochemical and genetic pathways that contribute to aging over time 2
- Age is a well-known traditional risk factor for cardiovascular disease, and individual age is commonly used in prediction of CVD incidence using different risk scores 3
- Chronic diseases, such as metaflammation, can accelerate the aging process and be considered a manifestation of accelerated aging 4
- Aging is the primary risk factor for most neurodegenerative diseases, including Alzheimer disease and Parkinson disease 5